Gpr81 Lactate Receptors in the Regulation of Cell Functional Activity

Boytsova, E. B.; Morgun, Andriy; Мартынова, Г. П.; Tohidpour, Abolghasem; Pisareva, N. V.; Ruzaeva, V A; Salmina, Alla

doi:10.20333/25000136-2016-5-15-23

Cited by 2 publications

(1 citation statement)

References 24 publications

(40 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These mechanisms are vulnerable to various damaging factors such as hypoxic exposure, bacterial and viral inflammation, or neurodegenerative diseases [ 31 ]. In particular, this vulnerability pertains to the systems implementing the reception and transport of lactate and NAD + (monocarboxylate transporters, molecules of Cx43, CD38, and GPR81) [ 32 , 33 ] as well as CD147, which is functionally conjugated with monocarboxylate transporters (MCT1, MCT4) and gamma-secretase. The latter is involved in proteolysis of the amyloid precursor protein and regulates the expression and activity of matrix metalloproteinases [ 34 , 35 ].…”

Section: Neurovascular Unit Of the Brainmentioning

confidence: 99%

Molecular Mechanisms of Proteins — Targets for SARS-CоV-2 (Review)

et al. 2020

View full text Add to dashboard Cite

The rapidly accumulating information about the new coronavirus infection and the ambiguous results obtained by various authors necessitate further research aiming at prevention and treatment of this disease. At the moment, there is convincing evidence that the pathogen affects not only the respiratory but also the central nervous system (CNS). The aim of the study is to provide an insight into the molecular mechanisms underlying the damage to the CNS caused by the new coronavirus SARS-CoV-2. Results. By analyzing the literature, we provide evidence that the brain is targeted by this virus. SARS-CoV-2 enters the body with the help of the target proteins: angiotensin-converting enzyme 2 (ACE2) and associated serine protease TMPRSS2 of the nasal epithelium. Brain damage develops before the onset of pulmonary symptoms. The virus spreads through the brain tissue into the piriform cortex, basal ganglia, midbrain, and hypothalamus. Later, the substantia nigra of the midbrain, amygdala, hippocampus, and cerebellum become affected. Massive death of neurons, astrogliosis and activation of microglia develop at the next stage of the disease. By day 4, an excessive production of proinflammatory cytokines in the brain, local neuroinflammation, breakdown of the blood-brain barrier, and impaired neuroplasticity are detected. These changes imply the involvement of a vascular component driven by excessive activity of matrix metalloproteinases, mediated by CD147. The main players in the pathogenesis of COVID-19 in the brain are products of angiotensin II (AT II) metabolism, largely angiotensin 1-7 (AT 1-7) and angiotensin IV (AT IV). There are conflicting data regarding their role in damage to the CNS in various diseases, including the coronavirus infection. The second participant in the pathogenesis of brain damage in COVID-19 is CD147 — the inducer of extracellular matrix metalloproteinases. This molecule is expressed on the endothelial cells of cerebral microvessels, as well as on leukocytes present in the brain during neuroinflammation. The CD147 molecule plays a significant role in maintaining the structural and functional integrity of the blood-brain barrier by controlling the basal membrane permeability and by mediating the astrocyte-endothelial interactions. Via the above mechanisms, an exposure to SARS-CoV-2 leads to direct damage to the neurovascular unit of the brain.

show abstract